Literature DB >> 8690463

CD27/CD70 interaction directly induces natural killer cell killing activity.

F C Yang1, K Agematsu, T Nakazawa, T Mori, S Ito, T Kobata, C Morimoto, A Komiyama.   

Abstract

The CD27 molecule is expressed on a portion of natural killer (NK) cells as well as T and B cells. To provide the functional capacity of CD27 molecule on NK cells, we here highly purified CD3- CD56+ NK cells by flow cytometry (purity > 98%), and investigated their NK cell activity via CD27/CD70 interaction using a CD70-transfectant by a 4 h 51Cr-release assay. The enhancement of NK activity by purified NK cells in the presence of interleukin-2 (IL-2) or interleukin-12 (IL-12) against CD70/Nalm-6 was not recognized as compared to against mock/Nalm-6. However, after a coculture with the fixed CD70/300-19, the purified NK cells increased the NK cell activity against K562, the value being 10 to 20% higher than coculture with the mock/300-19 in the presence of IL-2 or IL-12. The enhancement of NK activity was blocked by the addition of anti-CD70 monoclonal antibody (mAb). In addition, conjugation of NK cells to the target was increased by coculture with the CD70/300-19 without increased expression of adhesion molecules. In the parallel experiment, there was no increase in the killing capacity of NK cells. These results strongly show that CD27/CD70 interaction directly enhances NK activity in the presence of IL-2 or IL-12 by increasing the effector and target conjugate formation, indicating that CD27/CD70 interaction plays an important role in the cytotoxic function of NK cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690463      PMCID: PMC1456421          DOI: 10.1111/j.1365-2567.1996.tb00017.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.

Authors:  C D Platsoucas; F E Fox; E Oleszak; K Fong; M Nanno; C G Ioannides; P P Trotta
Journal:  Anticancer Res       Date:  1989 Jul-Aug       Impact factor: 2.480

2.  CD27 expression by a distinct subpopulation of human B lymphocytes.

Authors:  D Maurer; W Holter; O Majdic; G F Fischer; W Knapp
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

3.  The 1A4 molecule (CD27) is involved in T cell activation.

Authors:  K Sugita; Y Torimoto; Y Nojima; J F Daley; S F Schlossman; C Morimoto
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

4.  Natural killer cell and granulocyte Fc gamma receptor III (CD16) differ in membrane anchor and signal transduction.

Authors:  P Selvaraj; O Carpén; M L Hibbs; T A Springer
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

5.  Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen.

Authors:  R A van Lier; J Borst; T M Vroom; H Klein; P Van Mourik; W P Zeijlemaker; C J Melief
Journal:  J Immunol       Date:  1987-09-01       Impact factor: 5.422

6.  CD27-CD70 interactions regulate B-cell activation by T cells.

Authors:  T Kobata; S Jacquot; S Kozlowski; K Agematsu; S F Schlossman; C Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Comparative studies of human FcRIII-positive and negative natural killer cells.

Authors:  A Nagler; L L Lanier; S Cwirla; J H Phillips
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

Review 8.  A new superfamily of cell surface proteins related to the nerve growth factor receptor.

Authors:  S Mallett; A N Barclay
Journal:  Immunol Today       Date:  1991-07

9.  T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules.

Authors:  R E Schmidt; J P Caulfield; J Michon; A Hein; M M Kamada; R P MacDermott; R L Stevens; J Ritz
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

10.  CD11a-c/CD18 and GP84 (LB-2) adhesion molecules on human large granular lymphocytes and their participation in natural killing.

Authors:  T Timonen; M Patarroyo; C G Gahmberg
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

View more
  17 in total

1.  Naïve and memory B cells in the rhesus macaque can be differentiated by surface expression of CD27 and have differential responses to CD40 ligation.

Authors:  David Kuhrt; Seth Faith; Angela Hattemer; Amanda Leone; Donald Sodora; Louis Picker; Lisa Borghesi; Kelly Stefano Cole
Journal:  J Immunol Methods       Date:  2010-09-24       Impact factor: 2.303

Review 2.  Stimulating CD27 to quantitatively and qualitatively shape adaptive immunity to cancer.

Authors:  Timothy Nj Bullock
Journal:  Curr Opin Immunol       Date:  2017-03-17       Impact factor: 7.486

Review 3.  Immunobiology of tumor necrosis factor receptor superfamily.

Authors:  Tong Zhou; John D Mountz; Robert P Kimberly
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

4.  Acute Virus Control Mediated by Licensed NK Cells Sets Primary CD8+ T Cell Dependence on CD27 Costimulation.

Authors:  Jeffrey J Teoh; Awndre E Gamache; Alyssa L Gillespie; Michael D Stadnisky; Hideo Yagita; Timothy N J Bullock; Michael G Brown
Journal:  J Immunol       Date:  2016-10-24       Impact factor: 5.422

5.  Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies.

Authors:  Stephen M Ansell; Ian Flinn; Matthew H Taylor; Branimir I Sikic; Joshua Brody; John Nemunaitis; Andrew Feldman; Thomas R Hawthorne; Tracey Rawls; Tibor Keler; Michael J Yellin
Journal:  Blood Adv       Date:  2020-05-12

6.  Later development of Fas ligand-mediated cytotoxicity as compared with granule-mediated cytotoxicity during the maturation of natural killer cells.

Authors:  T Nakazawa; K Agematsu; A Yabuhara
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

7.  Involvement of CD27/CD70 interactions in antigen-specific cytotoxic T-lymphocyte (CTL) activity by perforin-mediated cytotoxicity.

Authors:  S Yamada; K Shinozaki; K Agematsu
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

8.  Loss of natural killer T cells promotes pancreatic cancer in LSL-KrasG12D/+ mice.

Authors:  Naveena B Janakiram; Altaf Mohammed; Taylor Bryant; Rebekah Ritchie; Nicole Stratton; Lydgia Jackson; Stan Lightfoot; Doris M Benbrook; Adam S Asch; Mark L Lang; Chinthalapally V Rao
Journal:  Immunology       Date:  2017-05-29       Impact factor: 7.397

Review 9.  Evolving synergistic combinations of targeted immunotherapies to combat cancer.

Authors:  Ignacio Melero; David M Berman; M Angela Aznar; Alan J Korman; José Luis Pérez Gracia; John Haanen
Journal:  Nat Rev Cancer       Date:  2015-08       Impact factor: 60.716

10.  Suberoylanilide hydroxamic acid (SAHA) and cladribine synergistically induce apoptosis in NK-LGL leukaemia.

Authors:  Xiaoshen Sun; Zainul S Hasanali; Allshine Chen; Dianzheng Zhang; Xin Liu; Hong-Gang Wang; David J Feith; Thomas P Loughran; Kailin Xu
Journal:  Br J Haematol       Date:  2014-10-04       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.